Viewing nowAdor Tablet 20 mg (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Ilseong IS Co., Ltd.

MFDS item code 201302989 · Approved 2013.01.31 · Insurance code 655403030
Improvement of hyperlipidemia; prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)
This medicine helps reduce the risk of cardiovascular diseases. It lowers the risk of myocardial infarction and stroke and is effective in preventing heart problems such as angioplasty and angina. It particularly reduces the risk of cardiovascular events in adult patients with multiple risk factors such as hypertension, smoking, and diabetes. Additionally, it helps reduce the risk of hospitalization due to congestive heart failure, aiding in the maintenance of heart health. In patients with hyperlipidemia, it contributes to lowering total cholesterol and LDL-cholesterol levels while increasing the levels of good cholesterol, HDL. It is also used as an adjunct treatment to lower LDL-cholesterol levels in pediatric patients. This medicine is effective in the prevention and treatment of heart and vascular diseases.
Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment, and may take this medicine at any time of day, with or without food. Hyperlipidemia: The recommended initial dose is 10 mg of atorvastatin once daily. However, patients who require a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (40 mg is for patients who require an LDL cholesterol reduction of 45 % or greater). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into consideration the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Patients with homozygous familial hypercholesterolemia: This medicine is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. Elderly patients: Efficacy and safety in patients aged 70 years or older are generally similar to those in the general adult patient population.
10 ~ 17 years: The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medicine higher than 20 mg in pediatric patients).
This medicine may cause symptoms related to the muscles, so if there is severe muscle pain or muscle weakness, or a significant increase in creatine kinase levels, discontinue use immediately and consult a doctor. Patients with liver function problems or active liver disease should not take this medicine, and if liver function test results are abnormally high, use should be stopped. Women who are pregnant or may become pregnant, and nursing women should not take this medicine, and women of childbearing age should use appropriate contraception while on treatment. Children, especially those under 10 years of age, should not take this medicine, and elderly patients or those with decreased kidney function should be cautious as they are at higher risk for muscle abnormalities. This medicine can alter the blood concentration when taken with certain medications, so make sure to inform your doctor or pharmacist if you are currently taking any other medications. Certain foods, such as grapefruit juice, may also affect the blood concentration of this medicine, so it is advisable to avoid excessive consumption. If symptoms such as fatigue, malaise, fever, muscle pain, or muscle weakness occur during treatment, inform healthcare providers immediately and receive an examination. This medicine may cause allergic reactions or severe skin rashes, and symptoms such as difficulty breathing, so if these occur, discontinue use immediately and visit a hospital. It is important to regularly check liver function and blood creatine kinase levels for abnormal signs.
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a tightly closed container to prevent air or moisture from entering, and it is best stored at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the efficacy of the drug and prevent deterioration.
White round film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Ilseong IS Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.